Literature DB >> 22511829

Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps.

Angus Nicoll1, Caroline Brown, Franz Karcher, Pasi Penttinen, Michala Hegermann-Lindencrone, Silvia Villanueva, Massimo Ciotti, Lucie Jean-Gilles, Sybille Rehmet, Jonathan S Nguyen-Van-Tam.   

Abstract

PROBLEM: Improving pandemic planning and preparedness is a challenge in Europe, a diverse region whose regional bodies (the Regional Office for Europe of the World Health Organization [WHO], the European Commission and the European Centre for Disease Prevention and Control) have overlapping roles and responsibilities. APPROACH: European pandemic preparedness indicators were used to develop an assessment tool and procedure based on the 2005 global WHO checklist for pandemic preparedness. These were then applied to Member States of WHO's European Region, initially as part of structured national assessments conducted during short visits by external teams. LOCAL
SETTING: Countries in WHO's European Region. RELEVANT CHANGES: From 2005 to 2008, 43 countries underwent a pandemic preparedness assessment that included a short external assessment visit by an expert team. These short visits developed into a longer self-assessment procedure involving an external team but "owned" by the countries, which identified gaps and developed plans for improving preparedness. The assessment tool and procedure became more sophisticated as national and local pandemic preparedness became more complex. The 2009 pandemic revealed new gaps in planning, surveillance communications and immunization. LESSONS LEARNT: Structured national self-assessments with support from external teams allow individual countries to identify gaps in their pandemic preparedness plans and enable regional bodies to assess the regional and global resources that such plans require. The 2009 pandemic revealed additional problems with surveillance, pandemic severity estimates, the flexibility of the response, vaccination, involvement of health-care workers and communication. European national plans are being upgraded and global leadership is required to ensure that these plans are uniformly applied across the region.

Mesh:

Year:  2012        PMID: 22511829      PMCID: PMC3324872          DOI: 10.2471/BLT.11.097972

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Influenza pandemic planning in Europe.

Authors:  W J Paget; J F Aguilera
Journal:  Euro Surveill       Date:  2001-09

2.  How prepared is Europe for pandemic influenza? Analysis of national plans.

Authors:  Sandra Mounier-Jack; Richard J Coker
Journal:  Lancet       Date:  2006-04-29       Impact factor: 79.321

3.  Experience and lessons from surveillance and studies of the 2009 pandemic in Europe.

Authors:  A Nicoll; A Ammon; A Amato Gauci; A Amato; B Ciancio; P Zucs; I Devaux; F Plata; A Mazick; K Mølbak; T Asikainen; P Kramarz
Journal:  Public Health       Date:  2010-01       Impact factor: 2.427

4.  Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

Authors:  J Mereckiene; S Cotter; J T Weber; A Nicoll; F D'Ancona; P L Lopalco; K Johansen; A M Wasley; P Jorgensen; D Lévy-Bruhl; C Giambi; P Stefanoff; L Dematte; D O'Flanagan
Journal:  Euro Surveill       Date:  2012-01-26

Review 5.  Closure of schools during an influenza pandemic.

Authors:  Simon Cauchemez; Neil M Ferguson; Claude Wachtel; Anders Tegnell; Guillaume Saour; Ben Duncan; Angus Nicoll
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

  5 in total
  9 in total

1.  Lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome.

Authors:  Parker S Woods; Lauren M Doolittle; Lucia E Rosas; Lisa M Joseph; Edward P Calomeni; Ian C Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-11       Impact factor: 6.011

2.  Assessing the use of hospital staff influenza-like absence (ILA) for enhancing hospital preparedness and national surveillance.

Authors:  Lydia N Drumright; Simon D W Frost; Alex J Elliot; Mike Catchpole; Richard G Pebody; Mark Atkins; John Harrison; Penny Parker; Alison H Holmes
Journal:  BMC Infect Dis       Date:  2015-03-01       Impact factor: 3.090

3.  Ethics-sensitivity of the Ghana national integrated strategic response plan for pandemic influenza.

Authors:  Amos Laar; Debra DeBruin
Journal:  BMC Med Ethics       Date:  2015-05-07       Impact factor: 2.652

4.  Intentions to perform non-pharmaceutical protective behaviors during influenza outbreaks in Sweden: a cross-sectional study following a mass vaccination campaign.

Authors:  Toomas Timpka; Armin Spreco; Elin Gursky; Olle Eriksson; Örjan Dahlström; Magnus Strömgren; Joakim Ekberg; Sofie Pilemalm; David Karlsson; Jorma Hinkula; Einar Holm
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

5.  Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.

Authors:  Anastasiya S Sokolova; O Cyrilliclga I Yarovaya; Dina V Korchagina; Vladimir V Zarubaev; Tatiana S Tretiak; Pavel M Anfimov; Oleg I Kiselev; Nariman F Salakhutdinov
Journal:  Bioorg Med Chem       Date:  2014-03-01       Impact factor: 3.641

6.  Infectious disease pandemic planning and response: Incorporating decision analysis.

Authors:  Freya M Shearer; Robert Moss; Jodie McVernon; Joshua V Ross; James M McCaw
Journal:  PLoS Med       Date:  2020-01-09       Impact factor: 11.069

7.  Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza.

Authors:  Stefan Kluge; Julian Schulze Zur Wiesch; Thomas Theo Brehm; Marc van der Meirschen; Annette Hennigs; Kevin Roedl; Dominik Jarczak; Dominic Wichmann; Daniel Frings; Axel Nierhaus; Tim Oqueka; Walter Fiedler; Maximilian Christopeit; Christian Kraef; Alexander Schultze; Marc Lütgehetmann; Marylyn M Addo; Stefan Schmiedel
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

8.  Spine Surgery and COVID-19: The Influence of Practice Type on Preparedness, Response, and Economic Impact.

Authors:  Joseph A Weiner; Peter R Swiatek; Daniel J Johnson; Philip K Louie; Garrett K Harada; Michael H McCarthy; Niccole Germscheid; Jason P Y Cheung; Marko H Neva; Mohammad El-Sharkawi; Marcelo Valacco; Daniel M Sciubba; Norman B Chutkan; Howard S An; Dino Samartzis
Journal:  Global Spine J       Date:  2020-08-07

9.  Learning from the past: did experience with previous epidemics help mitigate the impact of COVID-19 among spine surgeons worldwide?

Authors:  Joseph A Weiner; Peter R Swiatek; Daniel J Johnson; Philip K Louie; Garrett K Harada; Michael H McCarthy; Niccole Germscheid; Jason P Y Cheung; Marko H Neva; Mohammad El-Sharkawi; Marcelo Valacco; Daniel M Sciubba; Norman B Chutken; Howard S An; Dino Samartzis
Journal:  Eur Spine J       Date:  2020-06-04       Impact factor: 2.721

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.